---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-26-010195"
form_type: "8-K"
ticker: "ADCT"
cik: "0001771910"
company_name: "ADC Therapeutics SA"
filed_at: "2026-07-02T21:07:26+00:00"
generated_at: "2026-07-02T21:08:10.939229+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# ADC Therapeutics grants $2.9M cash and 1.1M RSU retention awards to CEO, CFO, CMO

## Summary
- CEO Ameet Mallik receives $1,795,500 cash and 675,000 RSUs; CFO Jose Carmona $541,842 cash and 203,700 RSUs; CMO Mohamed Zaki $568,974 cash and 213,900 RSUs.
- Cash awards payable July 15, 2026; subject to repayment if employment ends before June 30, 2027 (exceptions for termination without cause or for good reason).
- RSUs vest on June 30, 2027 or earlier upon termination without cause or for good reason, subject to continued employment.
- Awards approved by Board with advice of independent compensation consultant on June 30, 2026.

## SEC filing metadata
- accession: 0000950103-26-010195
- form_type: 8-K
- ticker: ADCT
- cik: 0001771910
- company_name: ADC Therapeutics SA
- filed_at: 2026-07-02T21:07:26+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1771910/000095010326010195/0000950103-26-010195-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1771910/000095010326010195/dp249055_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-26-010195
- JSON: https://secwatch.observer/filing/0000950103-26-010195.json
- Plain text: https://secwatch.observer/filing/0000950103-26-010195.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.